Rates of Suspected Hypersensitivity Reaction in HIV infected Adult treatment populations screened HLA-B*5701 negative prior to commencing Abacavir therapy: Meta-analysis of Data from GlaxoSmithKline and ViiV Healthcare Sponsored Clinical Trials (207831)

07/04/2017
02/04/2024
EU PAS number:
EUPAS18543
Study
Finalised
Documents
Study protocol
Initial protocol
English (156.89 KB - PDF) View document
Study results
Study results
English (791.87 KB - PDF) View document
Study report
Other information